Alphapharm

Alphapharm logo

Alphapharm is an Australian pharmaceutical company that specializes in the production and distribution of generic medications. Founded in 1982, Alphapharm has grown to become one of the leading suppliers of generic pharmaceuticals in Australia. The company is a subsidiary of Mylan, a global pharmaceutical company.

History

Alphapharm was established in 1982 with the aim of providing affordable and high-quality generic medications to the Australian market. Over the years, the company has expanded its product range and increased its market presence. In 2007, Alphapharm was acquired by Mylan, which further strengthened its position in the pharmaceutical industry.

Products

Alphapharm offers a wide range of generic medications across various therapeutic categories, including:

• Cardiovascular
• Central nervous system
• Gastrointestinal
• Infectious diseases
• Oncology
• Respiratory

The company's products are designed to be bioequivalent to their branded counterparts, ensuring that patients receive the same therapeutic benefits at a lower cost.

Manufacturing and Quality Control

Alphapharm operates state-of-the-art manufacturing facilities in Australia. The company adheres to stringent quality control measures to ensure that its products meet the highest standards of safety and efficacy. Alphapharm's manufacturing processes comply with the guidelines set by regulatory authorities such as the Therapeutic Goods Administration (TGA) in Australia.

Research and Development

Alphapharm invests in research and development to continuously improve its product offerings and develop new generic medications. The company's R&D efforts focus on creating bioequivalent formulations of existing drugs, as well as developing new delivery systems and dosage forms.

Corporate Social Responsibility

Alphapharm is committed to corporate social responsibility and actively participates in initiatives that promote public health and well-being. The company supports various community programs and collaborates with healthcare organizations to improve access to affordable medications.

See also

• Mylan
• Generic drug
• Pharmaceutical industry
• Therapeutic Goods Administration